Home › Funds › Saturn V Capital Management LP › ABVX

Saturn V Capital Management LP position in ABVX

ABIVAX SA · Health Care

Saturn V Capital Management LP reported holding 518,865 shares of ABVX (ABIVAX SA) in its Q2 2026 13F filing — a position valued at US$69.1M, representing 9.91% of its reported portfolio and ranking #3 among its reported holdings. Saturn V Capital Management LP has disclosed ABVX holdings in 10 of the last 10 reported quarters, going back to Q1 2024.

Latest position (Q2 2026)518.87K sh
Reported value held$69.14M
Portfolio Weight9.91%
First reportedQ1 2024
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Saturn V Capital Management LP's ABVX position evolved

Saturn V Capital Management LP first disclosed a stake in ABVX in Q1 2024 at 622,970 shares (US$8.9M). The position peaked in Q4 2025 at 649,179 shares, worth US$87.5M. Across 10 filings, Saturn V Capital Management LP increased the stake 5 time(s), trimmed it 4 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 518,865 shares valued at US$69.1M — a reduction of -23,831 shares quarter over quarter.. Notable position changes include a 29% increase in Q3 2025 (shares rose 59% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2024 622.97K $8.91M New
Q2 2024 627.76K $8.30M Add
Q3 2024 648.02K $7.47M Add
Q4 2024 653.07K $4.78M Add
Q1 2025 552.93K $3.46M Reduce
Q2 2025 622.48K $4.76M Add
Q3 2025 801.22K $68.02M Add
Q4 2025 649.18K $87.55M Reduce
Q1 2026 542.70K $60.43M Reduce
Q2 2026 518.87K $69.14M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABVX and 13F data

ABVX (ABIVAX SA) is a Health Care company. 72 other funds we track also report a position in ABVX — the largest reported positions include TCG Crossover Management, LLC (US$800.6M), Helikon Investments Ltd (US$371.4M), Darwin Global Management, Ltd. (US$348.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABVX

All ABVX fund holders →

FAQ

How long has Saturn V Capital Management LP held ABVX?

Saturn V Capital Management LP has disclosed ABVX holdings in 10 of the last 10 reported quarters, going back to Q1 2024.

What is Saturn V Capital Management LP's current position in ABVX?

As of Q2 2026, Saturn V Capital Management LP holds 518.87K shares of ABVX (ABIVAX SA), valued at $69.14M, representing 9.91% of its reported portfolio and ranking #3.

Has Saturn V Capital Management LP been buying or selling ABVX?

In the latest 13F filing (Q2 2026), Saturn V Capital Management LP reduced its position in ABVX. The position peaked in Q4 2025 at 649.18K shares.

Which other funds hold ABVX?

Other major institutional holders of ABVX include TCG Crossover Management, LLC, Helikon Investments Ltd, Darwin Global Management, Ltd., among 72 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.